Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Also known as: Refractory Diffuse Large B-cell Lymphoma (DLBCL) / B Cell Refractory Diffuse Large B-Cell Lymphoma / Diffuse Large B Cell Lymphoma Refractory / Refractory Diffuse Large B-Cell Lymphoma / Diffuse Large B-cell Lymphoma Refractory / Refractory Diffuse Large B Cell Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB13915 | Axicabtagene ciloleucel | A CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma. |
DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
DB16582 | Lisocabtagene maraleucel | A CAR T-cell therapy for treatment resistant or more severe B-cell lymphomas. |
DB16222 | Loncastuximab tesirine | An antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas. |
DB13881 | Tisagenlecleucel | A CAR T cell therapy for relapsed or refractory large B-cell lymphoma and diffuse large B-cell lymphoma. |